Description
Lansoprazole delayed-release (DR) is a medication in the class of proton pump inhibitors (PPIs) specifically formulated to provide a sustained-release effect, thereby prolonging its action. It is commonly utilized for the treatment of conditions that benefit from the reduction of gastric acid over an extended period, such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. When compared to immediate-release formulations, delayed-release lansoprazole can maintain a consistent suppression of gastric acid over a longer duration, optimizing therapeutic benefits.
Reviews
There are no reviews yet.